Clinical Guidance on the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in Adults with Type 1 Diabetes
{{output}}
This article provides a stepwise guidance on the safe use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) as adjunctive therapy in adults with type 1 diabetes (T1D). Here, we first identify the phenotypes within T1D most likely to benefit and then outl... ...
